A detailed history of Srs Capital Advisors, Inc. transactions in Galapagos Nv stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 40 shares of GLPG stock, worth $1,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Holding current value
$1,095
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$24.2 - $30.67 $968 - $1,226
40 New
40 $1,000
Q3 2022

Nov 03, 2022

BUY
$42.27 - $57.6 $887 - $1,209
21 New
21 $1,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.8B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.